FactaeThe Factual News

FDA approves Abbott's portable device for ketone and glucose monitoring

The FDA has approved Abbott's portable device for diabetic patients.

Published 2h1 sourceNotable
Lire en français
≈ 16s

The fact

The system enables real-time monitoring of ketones and glucose levels.

This innovation could enhance diabetes management in the US.

Click the link to read an article on the topic:
Explore this topic
What if you saw the whole news differently?Factae cross-checks hundreds of sources worldwide to keep only the fact, no opinion. Explore the front page.
Etats-UnisWorld map →
Follow topic →
Auto-synthesis from 1 media source · identified on August 25, 2026
← Back to home
Discover

Read more

All marches →
marches

SpaceX invests $100 billion in a Starship complex in Louisiana

3h · 1 sourcemarches50 %

Canada imposes 15 to 50% surtaxes on US imports

52m · 1 sourcemarches

Nvidia: Expected results could swing $280 billion in stock market value

16h · 1 sourcemarches

Wall Street rebounds on tech sector ahead of Nvidia results

2h · 1 sourcemarches

Washington announces economic offensive against Tehran

15h · 1 sourcemarches

SEC investigates stock market collapse linked to 'Situational Awareness'

23h · 1 source